NYSEInformation TechnologyElectronic ComponentsSnapshot 2026-07-23
Reading MEI? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a turnaround story in a tech sector facing headwinds. The current thesis state is cautious, given the company's recent earnings misses and elevated risks.
The market appears to have priced in a low expectations gap, indicating that it is not overly optimistic about MEI's near-term performance. The valuation is seen as cheap compared to peers, but the fundamentals suggest fragility.
Fundamentals are expected to remain under pressure in the near term, especially with a 44% probability of missing future earnings targets. Management is focused on achieving sales growth, but recent performance has been weak.
The long-term thesis hinges on several factors, including the potential for the Federal Reserve to cut interest rates and the performance of sector leaders like APH, GLW, and TEL. Additionally, any guidance cuts from MEI could significantly impact sentiment.
In the next 1 to 3 years, MEI's performance will depend on its ability to stabilize earnings and navigate sector dynamics. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The latest earnings report missed expectations. This performance is below what we see in the industry.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: If sector growth slows, it could hurt Methode's sales. This is important for future performance.
Confirms:Sector revenue growth has been below its median for two months in a row.
Disproves:Sector revenue growth stays above its median for two consecutive months.
Why it matters: Earnings results will show if the company can recover from the recent earnings miss. This impacts market perception.
Confirms one read:Earnings results show a big improvement from last quarter.
Confirms the other:Earnings results show another miss or decline in revenue.
Why it matters: Confirming net sales between $1,025M and $1,075M shows growth momentum. This supports the company's transformation efforts.
Confirms:Fiscal 2027 net sales reported within the guided range of $1,025M to $1,075M.
Disproves:Fiscal 2027 net sales reported below $1,025M.
Why it matters: The earnings report will update us on sales and profits. This helps us see how the company is doing.
Confirms one read:The earnings report shows net sales and Adjusted EBITDA are at or above guidance.
Confirms the other:The earnings report shows net sales and Adjusted EBITDA are below guidance.
Why it matters: GDP growth impacts overall economic health. Strong GDP can lead to better demand for Methode's products.
Confirms:GDP growth is reported above 2% for Q1 2026.
Disproves:GDP growth is reported below 1% for Q1 2026.
Why it matters: Keeping capex between $25M and $30M is key for financial health. It affects cash flow.
Confirms one read:Capital spending was between $25M and $30M.
Confirms the other:Capital spending is over $30M.
Why it matters: Hitting the Adjusted EBITDA target of $72M to $82M shows better profits. This is important for investor trust.
Confirms:Fiscal 2027 Adjusted EBITDA reported within the range of $72M to $82M.
Disproves:Fiscal 2027 Adjusted EBITDA is less than $72M.
Why it matters: Consistent free cash flow signals financial health. It reflects the company's ability to fund growth without external debt.
Confirms:Free cash flow reported consistent with fiscal 2026.
Disproves:Free cash flow is much lower than in fiscal 2026.
